Incidence and role of apoptosis in myelodysplastic syndrome: Morphological and ultrastructural assessment

Leukemia

Volumn 11, Issue 5, 1997, Pages 656-659

  Bogdanovic A D ^a   Trpinac, D P ^b   Jankovic G M ^a   Bumbasirevic V Z ^b   Obradovic M ^b   Colovic M D ^b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Dedinje Cardiovascular Institute   (Serbia)

Author keywords

Apoptosis; Incidence; Morphology; Myelodysplastic syndrome; Ultrastructure

Indexed keywords

APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER CLASSIFICATION; CELL ULTRASTRUCTURE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KARYOTYPE; LEUKOCYTE COUNT; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA;

EID: 0031004494     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400640     Document Type: Article

References (22)

1. Kerr JFR, Haimon BV. Definition and incidence of apoptosis: an historical perspective. In: Tomei DL, Cope FE (eds). Apoptosis: The Molecular Basis of Cell Death. Curr Comm Cell Mol Biology. Cold Spring Harbor Laboratory Press: New York, 1991 pp 5-31.
2. Lotem J, Sachs L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia 1996; 10: 925-931.
3. Cope FO, Willie JJ. Carcinogenesis and apoptosis. Paradigms and paradoxes in cell cycle and differentiation. In: Tomei DL, Cope FE (eds). Apoptosis: The Molecular Basis of Cell Death. Curr Comm Cell Mol Biology. Cold Spring Harbor Laboratory Press: New York, 1991; 61-87.
4. Yoshida Y. Hypothesis: apoptosis may be the mechanism respon-sible for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia 1993; 7: 144-146.
5. Bennet JM. Classification of the myelodysplastic syndromes. Clin Hematol 1986; 15: 909-923.
6. Novak A, Kruškić M, Ludoški M, Jurkovski M. Rapid method for obtaining high quality chromosome banding in the study of hematopoietic neoplasia. Cancer Genet Cytogenet 1994; 74: 109-114.
7. Hayatt MA. Basic Techniques of Transmission Electron Microscopy. Academic Press: Orlando, 1986, pp 57-61.
8. Clark DM, Lampert IA. Apoptosis is a common histopathological finding in myelodysplasia: the correlate of ineffective hematopoiesis. Leuk Lymphoma 1990; 2: 415-418.
9. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, Loew J, Marcus B, Khan Z, Chaney C, Showel J, Gregory S, Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86: 268-276.
10. Yoshida Y, Anzai N, Kawabata H. Apoptosis in myelodysplasia: a paradox or paradigm. Leuk Res 1995; 19: 887-891.
11. Bogdanović AD. Incidence and significance of apoptosis in myelodysplastic syndrome. Master thesis, University of Belgrade, School of Medicine, 1995.
12. Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z, Alvi S, Shetty V, Dameron S, Wright V, Adler S, Loew JM, Shott S, Ali SN, Preisler H. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 1995; 48: 143-145.
13. Huang S, Terstappen LWMM. Formation of haemopoietic microenvironment and haemopoietic stem cells from single human bone marrow stem cell. Nature 1992; 360: 745-748.
14. Greenberg PL. Myelodysplastic syndrome. In: Hoffman R (ed). Hematology, Basic Principles and Practice, 2nd edn. Churchill Livingstone: New York, 1995, pp 1098-1121.
15. Coutinho LH, Geary CC, Chang J, Harrison C, Testa NG. Functional studies of bone marrow hematopoietic and stromal cells in the myelodysplastic syndrome (MDS). Br J Haematol 1990; 75: 16-25.
16. Visani G, Zauli G, Tosi P, Fogli M, Cenacchi A, Finelli C, Gamberi B, Ottaviani E, Manofi S, Tura S. Impariment of GM-CSF production in myelodysplastic syndromes. Br J Haematol 1993; 84: 227-231.
17. Wetzler M, Kurzrock R, Estrov Z, Estey E, Talpaz M. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leuk Res 1995; 19: 23-34.
18. Verhoef GEG, De Schouwer P, Ceuppens J, Van Damme J, Goossens W, Boogaerts MA. Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 1992; 6: 1268-1272.
19. Seipelt G, Ganser A, Duranceyk H, Maurer A, Ottmann OG, Hoelzer D. Induction of TNFα in patients with myelodysplastic syndromes undergoing treatment with interleukin-3. Br J Haematol 1993; 84: 749-751.
20. Boogaerts MA. The role of growth factors in MDS - biological and clinical features. Symposium: Hematopoietic growth factors in myeloid diseases - recent progress. Second European Haematology Association Meeting, Paris, June 1996.
21. Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, Parcharidou A, Dar S, Venugopal P, Borok R, Gezer S, Showel J, Loew J, Robin T, Rifkin S, Alston D, Hernandez B, Shah R, Kaizer H, Gregory S, Preisler H. A paradigm shift in myelodysplastic syndromes. Leukemia 1996; 10: 1648-1652.
22. Bogdanović AD, Janković CM, Čolović MD, Trpinac DP, Bumbaširević VŽ. Apoptosis in bone marrow of myelodysplastic patients. Blood 1996; 87: 3064 (letter).